These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8215983)

  • 21. Gene therapy in the central nervous system: the use of recombinant retroviruses.
    Suhr ST; Gage FH
    Arch Neurol; 1999 Mar; 56(3):287-92. PubMed ID: 10190818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo adenovirus-mediated gene transfer for Parkinson's disease.
    Horellou P; Bilang-Bleuel A; Mallet J
    Neurobiol Dis; 1997; 4(3-4):280-7. PubMed ID: 9361305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the pharmacology of neurological gene therapy.
    Lowenstein PR; Castro MG
    Curr Opin Pharmacol; 2004 Feb; 4(1):91-7. PubMed ID: 15018845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-directed gene transfer vectors.
    Ferry N; Heard JM
    Hum Gene Ther; 1998 Sep; 9(14):1975-81. PubMed ID: 9759925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene technology based therapies in the brain.
    Wirth T; Ylä-Herttuala S
    Adv Tech Stand Neurosurg; 2006; 31():3-32. PubMed ID: 16768302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses.
    Puumalainen AM; Vapalahti M; Agrawal RS; Kossila M; Laukkanen J; Lehtolainen P; Viita H; Paljärvi L; Vanninen R; Ylä-Herttuala S
    Hum Gene Ther; 1998 Aug; 9(12):1769-74. PubMed ID: 9721087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retroviruses: delivery vehicle to the liver.
    Grossman M; Wilson JM
    Curr Opin Genet Dev; 1993 Feb; 3(1):110-4. PubMed ID: 8453268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel strategy of cell targeting based on tissue-specific expression of the ecotropic retrovirus receptor gene.
    Igarashi T; Suzuki S; Takahashi M; Tamaoki T; Shimada T
    Hum Gene Ther; 1998 Dec; 9(18):2691-8. PubMed ID: 9874267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus vectors to transfer genes into neurones: implications for gene therapy of neurological disorders.
    Bain D; Wilkinson GW; Preston CM; Castro MG; Lowenstein PR
    Gene Ther; 1994; 1 Suppl 1():S68. PubMed ID: 8542414
    [No Abstract]   [Full Text] [Related]  

  • 30. Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease.
    Bowers WJ; Howard DF; Federoff HJ
    Exp Neurol; 1997 Mar; 144(1):58-68. PubMed ID: 9126153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of hybrid viral vectors for gene therapy.
    Huang S; Kamihira M
    Biotechnol Adv; 2013; 31(2):208-23. PubMed ID: 23070017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.
    Jacobs A; Breakefield XO; Fraefel C
    Neoplasia; 1999 Nov; 1(5):387-401. PubMed ID: 10933054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease.
    Dunbar CE
    Annu Rev Med; 1996; 47():11-20. PubMed ID: 8712765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus-mediated gene transfer to treat neurologic disease.
    Smith GM
    Arch Neurol; 1998 Aug; 55(8):1061-4. PubMed ID: 9708955
    [No Abstract]   [Full Text] [Related]  

  • 35. The principles of gene therapy for the nervous system.
    Karpati G; Lochmüller H; Nalbantoglu J; Durham H
    Trends Neurosci; 1996 Feb; 19(2):49-54. PubMed ID: 8820867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene transfer to neurons using herpes simplex virus-based vectors.
    Fink DJ; DeLuca NA; Goins WF; Glorioso JC
    Annu Rev Neurosci; 1996; 19():265-87. PubMed ID: 8833444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of recombinant adenovirus for metabolic engineering of mammalian cells.
    Becker TC; Noel RJ; Coats WS; Gómez-Foix AM; Alam T; Gerard RD; Newgard CB
    Methods Cell Biol; 1994; 43 Pt A():161-89. PubMed ID: 7823861
    [No Abstract]   [Full Text] [Related]  

  • 38. Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease.
    Tuszynski MH; Yang JH; Barba D; U HS; Bakay RA; Pay MM; Masliah E; Conner JM; Kobalka P; Roy S; Nagahara AH
    JAMA Neurol; 2015 Oct; 72(10):1139-47. PubMed ID: 26302439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic therapy for the nervous system.
    Bowers WJ; Breakefield XO; Sena-Esteves M
    Hum Mol Genet; 2011 Apr; 20(R1):R28-41. PubMed ID: 21429918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral vectors for therapy of neurologic diseases.
    Choudhury SR; Hudry E; Maguire CA; Sena-Esteves M; Breakefield XO; Grandi P
    Neuropharmacology; 2017 Jul; 120():63-80. PubMed ID: 26905292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.